Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma

NCT00588666 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Myeloproliferative Disorder
Urothelial Carcinoma
Cancer

Interventions

DRUG: Bevacizumab
DRUG: Carboplatin
DRUG: Gemcitabine

Sponsor

Memorial Sloan Kettering Cancer Center